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ABSTRACT. Background: One decade after univer­
sal salt iodization in Iran, goiter prevalence, urinary 
iodine concentration (UIC) and thyroperoxidase anti­
body (TPOAb) values were assessed among school­
children in Gorgan, Iran. Methods: From 2003-2004, 
500 girls and 900 boys aged 7-11 yr were evaluated 
for goiter by palpation. UIC was measured in 183 
randomly-selected goitrous children. Serum TSH, 
T., and TPOAb were measured in 53 goitrous and 
30 non-goitrous children with adequate UIC. Re­
sults: Goiter was detected in 370 (26.4%) children. 
Goiter was present in 31% of girls and 17% of boys 
age 9 (p<0.012); 37% of girls and 20% of boys age 
10 (p<0.003); and 52%of girls and 19%of boys age 
11 (p<0.0001 ). Median (range) UIC for all goitrous 
children sampled was 190 (20-600) µg/I; 220 (30­
590) in boys and 170 (20-600) in girls (p=0.001 ). 
Eight point seven percent of goitrous children and 
22% of goitrous girls aged 10-11 had UIC<100 µg/I, 
while 47% of the goitrous children had UIU.200 µg/ 
I. TPOAb was present in 52.8% of goitrous children 
and 10% of non-goitrous children (p=0.0001 ). TPO­
Ab was present in 53.9% of 10-11 and 22.7%of 7-9 
yr old goitrous and non-goitrous children (p=0.003) 
with adequate UIC. Median (range) TSH was 2.9 
(0.3-10.9) mlU/I in TPO-positive and 1.8 (0.5-4.1) 
in TPO-negative children (p=0.001 ). Conclusions: 
Gorgan, Iran, is an iodine-sufficient area and almost 
halfof schoolchildren have more than adequate UIC. 
TPOAb is associated with endemic goiter. Despite 
sufficient UIC overall, some school-aged girls remain 
at risk of iodine deficiency. 
(J. Endocrinol. Invest. 28: 727-733, 2005) 
©2oos, Editrice Kurtis 
INTRODUCTION 
The term "iodine deficiency disorders" emphasizes 
the wide spectrum of consequences of iodine defi­
ciency, from simple goiter to cretinism (1). Iodine is 
essential for thyroid hormone synthesis and, conse­
quently, for the regulation of cell metabolism and 
for growth, especially of the brain during fetal and 
early post-natal life (2). In the last decade, iodine de­
ficiency has been recognized as the most common 
preventable cause of mental retardation worldwide 
(3). Worldwide, 2.2 billion people (38% of the world's 
population) are at risk of iodine deficiency and 740 
million (13%) have goiter. The progress toward 
correction of iodine deficiency globally in the past 
decade is a public health triumph unprecedented 
in the field of non-infectious disorders (4). Although 
acute supplementation of iodine in iodine-deficient 
areas has occasionally been associated with iodine­
induced hyperthyroidism (5-7) and autoimmune 
thyroiditis (8), the benefits of correcting iodine defi­
ciency far outweigh the risks (9, 10). 
The prevalence of goiter in Iran ranged from 10-60% 
in 1968 (11). Because 20 million people were at risk 
of iodine deficiency, mandatory iodization of all salt 
for household use was legislated in 1994. A 1996 
comprehensive national assessment of goiter preva­
lence and urinary iodine concentration (U IC) demon­
strated adequate iodine intake among school-aged 
children in 26 provinces (12). Iran has recently been 
declared an iodine sufficient area (13). However, 
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goiter remained endemic in all provinces in 1996, 
and was present in > 40% of children in 20 provinces 
(12). Subclinical hypothyroidism was present in 2.2% 
of 1400 adults in Tehran in 1999-2000, and subclini­
cal hyperthyroidism was present in 0.42% (14). Posi­
tive thyroid peroxidase (TPO) and thyroglobulin an­
tibody levels were present in 12.5 and 16.8% of this 
population, respectively. No information is available 
about the prevalence of thyroid antibodies in Iran 
prior to iodine supplementation. 

Gargan, a city in northern Iran previously governed 

by Mazandaran Province, has been a part of Golestan 
Province since 1997. The present study was conduct­
ed to determine goiter prevalence among Gargan 
schoolchildren, to determine UIC values in those with 
goiter, and to assess whether elevated TPO antibody 
(TPOAb) levels were more common among school­
children with goiter than those without goiter. 
MATERIALS AND METHODS 
Goiter prevalence and U/C measurement 
Subjects 
All schools belong to 1 of 2 major educational districts in Gar­
gan. From April to June 2003, a total of 1400 (800from district 
1 and 600 from district 2) children aged 7-11 yr were recruited 
from 12 randomly-selected schools in different areas of Gargan. 
The sampling strategy was designed to reflect the distribution of 
children in each district (15). All procedures fol lowed were in ac­
cordance with the ethical methods of the institutional committee 
on human experimentation. Written consent was obtained from 
parents and/or school authorities, where required. Efforts were 
made to ensure the presence of al I students at the time of clinical 
examination. 
Goiter grading 
Thyroid size was determined by palpation by a single experienced 
observer (H.R.B). Goiter size was graded as 0, 1, and 2 according 
to the WHO/UN ICEF/ICCIDD classification (15). 
Urine samples and laboratory methods 
Spot morning urine samples were obtained from 183 randomly­
selected children with goiter. UIC was measured using the Sand­
ell-Kolthoff method (16-18). Results were categorized as follows: 
mild iodine deficiency, 50-99 µg/I; moderate iodine deficiency, 
20-49 µg/I; and severe iodine deficiency, <20 µg/I. Values be­
tween 100-199, 200-299, and ;;.300 µg/I were considered as 
adequate, more than adequate, and excessive iodine intakes, 
respectively (19, 20). 
Assessment ofTPOAb and thyroid function tests 
Subjects 
A case-control study was performed to assess the association be­
tween goiter and TPOAb levels. Blood and repeat urine samples 
were obtained from all goitrous children identified in the larger 
study who had adequate UIC values (100-199 µg/I). Blood and 
urine samples were also obtained from eligible goitrous children 
from other city schools. From these children, a subgroup of 53 
children with both goiter and adequate UIC levels was selected 
to serve as the cases. Children with low or excessive UIC values 
(15) were specifically excluded from th is subgroup. Children with 
thyroid pain, recent viral infections, diabetes mellitus and other 
systemic disorders, anemia, or a history of thyroid-affecting drug 
consumption during the previous 2 months were also excluded. 
Thirty healthy age, sex, weight, and height-matched non-goitrous 
controls with adequate UIC were consecutively recruited with pa­
rental permission. 
Laboratory methods 
Serum TSH, T 4 , and TPOAb levels were measured using the ELISA 
method (DRG Diagnostics, USA). Normal TSH values in children 
aged 6-15 yr were 0.7-5.7 mlU/I. Normal T4 values in children 
aged 6-10 and 11-15 yr were 82-171 and 71-151 nmol/I, respec­
tively (21). TPOAb levels >75 IU/ml were considered abnormal 
(positive). 
Statistical analyses 
The children were divided into older (10-11 yr) and younger (7-9 
yr) age groups (22). Categorical variables were assessed using 
z2 and Fisher's exact tests. Student's t, Mann-Whitney U, and 
Kruskal-Wall is analysis of variance (AN OVA) tests were employed 
for continuous variables. SPSS software package 9.05 (SPSS Inc., 
Chicago, IL) was used for the statistical analyses. p values <0.05 
were considered significant. 
RESULTS 
Goiter prevalence and UIC values 
Goiter prevalence by school district 
The gender distribution in district 1 (300 girls and 
500 boys) was similar to that in district 2 (200 girls 
and 400 boys; p~0.12). Goiter was detectable 
by palpation in 370 children (26.4%). Goiter was 
detected in 196 (24.5%) and 174 (29%) children in 
districts 1and2, respectively(p~0.08). Grade 1 goit­
ers were present in 173 (21.6%) children from district 
1 and 148 (24.7%) from district 2; grade 2 goiters 
were present in 23 (2.9%) children in district 1 and in 
26 (4.3%) in district 2 (p~0.45). Goiter was detected 
in 97 girls (32.3%) from district 1 and 76 girls (38%) 
from district 2 (p~0.23). Goiter was present in 99 
boys (19.8%) from district 1 and 98 boys (24.5%) 
from district 2 (p~0.11). 
Goiter prevalence by sex 
Goiter was detected in 173 (34.6%) of 500 girls and 
197 (21.9%) of 900 boys. The prevalence of goiter 
was higher in girls than in boys in both districts 
(p<0.001). Table 1 shows goiter grades for all sub­
jects by age group and sex. 
Goiter prevalence by age group and sex 
The prevalence of goiter was higher in older than in 
younger girls [p~0.0002; odds ratio 2.1, 95% confi­
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Table 1 - Prevalence ofgoiter among schoolchildren, Gargan, Iran 2003-2004. 
Goiter grade by palpation Girls by age group 
no.(%) 
10-11 yr 7-9yr 
Not palpable 111 (S6) 216(72) 
Grade 1 73 (37) 70(23) 
Grade 2 16(8) 14 (S) 
Total 200 300 
Boys by age group All children 
no.(%) 
10-11 yr 7-9 yr 
290(81) 413 (76) 1030(74) 
67 (19) 111 (21) 321 (23) 
3 (1) 16(3) 49(4) 
360 S40 1400 
dence interval (Cl) 1.4-3.0]. Goiter prevalence did not 
differ by age group in boys. There was no difference 
in goiter prevalence between the younger girls and 
the younger boys. However, among children age 10­
11, goiter prevalence was higher in girls than in boys 
(p<0.0001; odds ratio 3.3, 95% Cl 2.27-4.87). 
UIC values 
Iodine concentration was assayed in urine samples 
from the 183 children with thyroid enlargement 
(Tables 2 and 3). The median UIC in all children with 
goiter was 190 µg/I. The median UIC value was higher 
in boys (220 µg/I) than in girls (170 µg/I) (p~0.001). 
Median UIC did not vary by age group. UIC<50 and 
<100 µg/I were present in 4 (2.2%) and 16 (8.7%) of 
children, respectively. Among children with U IC ;,200 
µg/I, median UIC values did not differ by gender. 
Assessment of thyroid function and autoantibodies 
TPOAb 
In the case-control study, elevated TPOAb levels 
were present in 28 (52.8%) of the 53 children with 
goiter and in 3 (10%) of the 30 non-goitrous children 
(p~0.0001; odds ratio 10.1, 95% Cl 2.72-37.32) 
(Table 4). Elevated TPOAb levels were present in 
20 (76.9%) of those with grade 2 compared to 8 
(29.6%) with grade 1 goiters (p~0.001; odds ratio 
7.9, 95%CI 2.31-27.10). The prevalence of elevated 
TPOAb levels was also higher in children with grade 
2 goiters compared to the children without goiter 
(p<0.0001; odds ratio 30, 95% Cl 6.68-134.68). 
Among all children in the case-control study (in­
cluding children with and without goiters), 21 of 39 
(53.9%) 10-11 yr olds and 10 of 44 (22.7%) 7-9 yr olds 
had elevated TPOAb values (p~0.003; odds ratio 
3.97, 95%CI 1.54-10.21). Nineteen of 32 (59.4%) girls 
with goiter and 1 of 19 (5.3%) girls without goiter had 
elevated TPOAb values (p~0.0001; odds ratio 26.3, 
95%CI 3.12-222.19). Nine of 21 (42.9%) boys with 
goiter and 2 of 11 (18.2%) boys without goiter had 
positive TPOAb (p~0.25). The prevalence of elevated 
TPOAb levels did not differ between girls and boys. 
UIC values between 150-199 µg/I were present in 11 
(35.5%) of 31 TPOAb-positive and in 8 (15.4%) of 52 
TPOAb-negative subjects (p~0.035; odds ratio 3.0, 
95%CI 1.06-8.67). 
Thyroid function assessment 
Among the 83 children in whom thyroid function 
tests were obtained, the median (range) TSH values 
were 2.4 (0.3-10.9) mlU/I in the children with goiter 
and 1.7 (0.5-3.5) mlU/I in those without thyroid en­
largement (p~0.004). Serum TSH values were higher 
in children with grade 2 goiters 2.7 (0.3-10.9) mlU/I 
than in those with grade 1 goiters 1.8 (0.5-5.0) mlU/I 
(p~0.047). Children with grade 1 goiter and those 
without thyroid enlargement had similar TSH values 
(p~0.1). Median (range) serum TSH concentrations 
Table 2 - Prevalence of urine iodine concentration (UIC) levels by age group and sex among schoolchildren with goiter, Gargan, 
Iran 2003-2004. 
UIC (µg/I) Girls by age gr
no.(%) 
oup Boys by age gr
no.(%) 









2 (4) 16(9) 
100-199 (adequate) 1S (37) 33 (SS) 11 (42) 22 (39) 81 (44) 
>200 (h;gh) 17 (41) 22 (37) 1S (S8) 32 (S7) 86(47) 
Total 41 60 26 S6 183 
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Table 3 - Prevalence of urine iodine concentration (UIC) levels by with low serum TSH values (range 0.3-0.5 mlU/I) had 
goiter grade among schoolchildren with goiter, Gargan, Iran 2003­ normal T4 values (range 105-155 nmol/I). 2004. Abnormal (elevated or low) TSH levels were present in 
UIC (µg/I) Goiter grade All children with 7 (22.6%) of 31 TPOAb positive and in 1 (1.9%) of 52 
no.(%) goiter TPOAb negative children (p~0.004; odds ratio 14.9, 
95% Cl: 1.73-127.79). There were 3 girls with elevated 2 
serum TSH values, all aged 8-10 yr with grade 2 goit­
<100(1ow) 13 (7) 3 (2) 16(9) 
ers. TSH and T4 values were 6.2 mU/I and 51 nmol/I 
100-199 74 (40) 7 (4) 81 (44) in the first, 8.0 mU/I and 107nmol/I in the second, and 
(adequate) 10.9 mU/I and 53 nmol/I in the third case. All 3 girls 
>200 (h;gh) 	 80(44) 6(3) 86(47) complained of fatigue and dry skin; the 2 girls with low 
T4 values also complained of constipation. Three girls Total 167 16 183 (2 with grade 2 goiter and 1 without goiter) and 2 boys 
(one with grade 1 and 1 with grade 2 goiter) had low 
serum TSH values (between 0.3-0.5 mU/I), but all had 
were 2.9 (0.3-10. 9) mlU/I in the children with positive normal T4 values (range 105-155 nmol/I). None of these 
TPOAb and 1.8 (0.5-4.1) mlU/I in those with nega­ children had a known family history of autoimmune thy­
tive TPOAb (p~0.001). Median (range) serum TSH roid disorders. 
concentrations were 2.1 (0.4-10.9) mlU/I in older and 
1.7 (0.25-6.2) mlU/I in younger children (p~0.004). DISCUSSIONNo difference was found in serum TSH values be­
tween girls and boys among children with (p~0.27) In 1996, following universal salt iodization in Iran, a na­
or without goiter (p~1.0). Mean serum T4 values tional survey demonstrated that endemic goiter per­
were similar in the children with and without thyroid sisted among schoolchildren despite the presence of 
enlargement (110±29 vs 107±9 nmol/I; p~0.48). sufficient U IC values (12). This was assumed to be due 
The prevalence of elevated serum TSH values did to residual goiter from the previous period of iodine 
not differ between goitrous and non-goitrous chil­ deficiency (23). By the yr 2003, iodized salt had been 
dren (p~0.29). Two (4.1 %) of the children with grade consumed for nearly a decade in Iran and it was antici­
2 goiter had elevated serum TSH (6.2 and 10. 9 mlU/ pated that goiter prevalence would be reduced. 
I) and low serum T4 (51 and 53 nmol/I) values. All 5 The present study demonstrates that, despite ade­
children (4 with thyroid enlargement and 1 without) quate UIC values, palpable goiter remains endemic 
Table 4 Thyroid function and thyroperoxidase antibodies (TPOAb) in children with and without goiter. 
Children with goiter Children without goiter p-value 
No. 	 53 30 
Female (no.,%) 	 32 (60%) 19(63%) 0.79 
Grade 0 goiter 	 0 30(100%) 
Grade 1 goiter 	 27 (51%) 0 
Grade 2 goiter 	 26(49%) 0 
Age(yr; mean±SD) 	 9.4±1.3 9.1 ±1.3 0.30 
Height (cm; mean±SD) 	 130±8.3 128±6.3 0.33 
Weight (kg; mean±SD) 	 28.0±6.9 26.7±5.2 0.38 
UIC (µg/I; median, range) 	 120 I 100-1801 130 (100-180) 0.16 
TSH (mU/I; median, range) 	 2.4 (0.3-10.9) 1.7 (0.5-3.5) 
T4 (nmol/I; mean±SD) 	 110±29 107±9 0.48 
TPOAb (no.,%) 	 28(52.8%) 3 (10%) 0.0001 
TPOAbtiter 150(9-870) 37.5(6.7-130) <0.0001 
(U/ml; median, range) 
U IC: urinary iodine con cent ration. 
0.004 
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in Gargan, particularly among girls. Universal salt io­
dization in Iran has resulted in higher-than-adequate 
iodine intake in 38.6% of goitrous girls and 57.3% 
of goitrous boys. Despite iodine sufficiency in the 
overall population, low UIC was present in 22% of 
goitrous girls 10-11 yr of age. Among children with 
adequate iodine intake, children with goiter were 
more likely to have elevated serum TPOAb levels 
than non-goitrous children. Endemic goiter has been 
associated with the presence of thyroid antibodies 
in some, but not all, previous reports (24, 25). The 
present study suggests that autoimmunity may play 
a role in the etiology of endemic goiter in Gargan. 
Goiter prevalence in the present study was lower 
than that reported in Mazandaran Province in 1994 
(54%) (12), but much higher than the <5% expected 
in an iodine-replete area (23). The presence of goiter 
was not due to ongoing iodine deficiency, as UIC val­
ues were adequate (15, 26). The high prevalence of 
goiter in children despite dietary iodine sufficiency 
suggests that evaluation for dietary goitrogens and 
for pre-existing and iodine-induced autoimmunity, 
as done in India (27), may be warranted. The greater 
sensitivity and decreased specificity and precision 
(28) of World Health Organization (WHO)'s 1994 
(15) as compared to the 1960 (29, 30) goiter clas­
sifications may have contributed to an overestima­
tion of goiter prevalence in the present study (31). 
Ultrasonographic measurements would have been 
more precise (32-34), but ultrasonography was not 
available for a survey of these children. 
In the present study, goiter prevalence was signifi­
cantly higher among girls age 10-11 yr than among 
girls age 7-9 yr. The higher prevalence of goiter in 
older girls could be explained as a residual effect of 
iodine deficiency in utero and/or in early life; these 
girls were born just around the time that universal 
iodine supplementation was enacted. Alternatively, 
there might be an increased need for iodine in pu­
bertal girls, making older girls more prone to iodine 
deficiency. Particularly high goiter rates have been 
previously reported among adolescent girls in io­
dine-deficient areas (20). In iodine-replete areas, 
greater thyroid size (35) and lower UIC values (36) 
have been previously reported among girls during 
early adolescence. It is known that growth factors 
and sex steroids influence thyroid growth at puberty, 
with a maximum growth rate at 12.5 yr of age (37). 
Goiter was 1.9 times more frequent in girls than in 
boys. In addition, it was noted that low UIC values 
in older girls were significantly more frequent than 
in older boys. This could result from lower dietary 
iodine intake (35) and/or higher goitrogen intake, 
greater susceptibility to goitrogens, or the earlier 
initiation of pubertal changes (38) and growth spurt 
(39) in girls. Further studies are warranted. Whatever 
the cause(s), some early adolescent girls in Gargan 
are at risk of iodine deficiency, despite salt iodization, 
and may require additional iodine supplementation 
via multivitamin preparations (40). 
Elevated UIC values were present in 47% of the goi­
trous children. Because random morning urine col­
lections may sample UIC at its nadir (41), it is prob­
able that UIC values were even higher during other 
hours of the day. Boys had significantly higher iodine 
intakes than girls, possibly reflecting differences in 
dietary patterns (35). The nature of these dietary dif­
ferences is unknown, although it is suspected that 
boys eat more salty snack food than girls. The lack 
of U IC measurements in non-goitrous children in the 
present study precluded the assessment of an asso­
ciation between high UIC levels and the occurrence 
of goiter in the children studied. 
To assess whether endemic goiter in Gargan is a non­
autoimmune residual effect of previous iodine defi­
ciency, or whether it is associated with autoimmunity 
(42), a case-control subgroup study was conducted. 
Even among children with adequate iodine intake, 
elevated TPOAb were observed in 52.8% of the goi­
trous children (76.9%grade 2 and 29.6%grade 1goit­
ers). The odds for the presence of elevated TPOAb 
levels were 10 times higher in the goitrous than in the 
non-goitrous children. Therefore, it seems thatthyroid 
autoimmunity could be a cause of endemic goiter in 
Gargan schoolchildren. A high prevalence ofTPOAb 
positivity has also been observed among goitrous 
children and adolescents following iodine supple­
mentation in Germany and Azerbaijan (43, 44). 
Children with UIC values in the upper halfofthe recom­
mended range (150-199 µg/I) had a significantly higher 
prevalence of elevated TPOAb levels than children 
with UIC values in the lower half of the recommended 
range (100-149 µg/I). Therefore, it is possible that chil­
dren with excessive UIC (excluded in this study), might 
have even higher TPOAb concentrations. We plan a 
future study to determine the prevalence of goiter 
(by ultrasound) and of thyroid autoantibodies among 
schoolchildren with more varied UIC values. 
The occurrence of biochemical hypothyroidism (el­
evated TSH) was significantly higher in the TPOAb 
positive children than in the children without elevated 
TPOAb. The prevalence of hypothyroidism was much 
lower than that observed in German schoolchildren 
following iodine supplementation, where 15 and 26% 
of the subjects had hypothyroidism and hyperthyro­
tropinemia, respectively(43). Although 7 children with 
palpable goiter and 1 child without goiter (9.6%) had 
a low serum TSH value, none of them had TSH values 
<0.1 mlU/I. Therefore, no children met criteria forsub­
clinical or overt hyperthyroidism. 
731 
H.R. Bazrafshan, S. Mohammadian, A. Ordookhani, et al. 
In conclusion, Gargan is an iodine-sufficient area ac­
cording to UIC values. However, even after a decade 
of universal salt iodization in Iran, goiter remains 
endemic in this city. Although some older girls with 
goiter had low U IC, most of the goitrous children had 
high dietary iodine intake. TPOAb may contribute to 
the development of endemic goiter among school­
age children in Gargan, Iran. 
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